From drugs to deprivation: a Bayesian framework for understanding models of psychosis
Top Cited Papers
Open Access
- 28 May 2009
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 206 (4) , 515-530
- https://doi.org/10.1007/s00213-009-1561-0
Abstract
Various experimental manipulations, usually involving drug administration, have been used to produce symptoms of psychosis in healthy volunteers. Different drugs produce both common and distinct symptoms. A challenge is to understand how apparently different manipulations can produce overlapping symptoms. We suggest that current Bayesian formulations of information processing in the brain provide a framework that maps onto neural circuitry and gives us a context within which we can relate the symptoms of psychosis to their underlying causes. This helps us to understand the similarities and differences across the common models of psychosis. The Bayesian approach emphasises processing of information in terms of both prior expectancies and current inputs. A mismatch between these leads us to update inferences about the world and to generate new predictions for the future. According to this model, what we experience shapes what we learn, and what we learn modifies how we experience things. This simple idea gives us a powerful and flexible way of understanding the symptoms of psychosis where perception, learning and inference are deranged. We examine the predictions of the cognitive model in light of what we understand about the neuropharmacology of psychotomimetic drugs and thereby attempt to account for the common and the distinctive effects of NMDA receptor antagonists, serotonergic hallucinogens, cannabinoids and dopamine agonists. By acknowledging the importance of perception and perceptual aberration in mediating the positive symptoms of psychosis, the model also provides a useful setting in which to consider an under-researched model of psychosis—sensory deprivation.Keywords
This publication has 166 references indexed in Scilit:
- Reinforcement learning can account for associative and perceptual learning on a visual-decision taskNature Neuroscience, 2009
- Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairmentNeuroImage, 2009
- Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of ManiaNeuropharmacology, 2009
- Acetylcholine contributes through muscarinic receptors to attentional modulation in V1Nature, 2008
- A neurocognitive animal model dissociating between acute illness and remission periods of schizophreniaPsychopharmacology, 2008
- Placebo effects: clinical aspects and neurobiologyBrain, 2008
- Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humansPsychopharmacology, 2008
- Selective Reinforcement Learning Deficits in Schizophrenia Support Predictions from Computational Models of Striatal-Cortical DysfunctionBiological Psychiatry, 2007
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Glutamate and schizophreniaTrends in Pharmacological Sciences, 1990